Utilization of the remote monitoring of cardiac implantable electronic devices in a diverse demographic cohort: Insights from a single‐center observation
- 27 November 2023
- journal article
- research article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 47 (2) , 185-194
Abstract
Background: Despite its clinical benefits, patient compliance to remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) varies and remains under-studied in diverse populations.Objective: We sought to evaluate RM compliance, clinical outcomes, and identify demographic and socioeconomic factors affecting RM in a diverse urban population in New York.Methods: This retrospective cohort study included patients enrolled in CIED RM at Montefiore Medical Center between December 2017 and May 2022. RM compliance was defined as the percentage of days compliant to RM transmission divided by the total prescribed days of RM. Patients were censored when they were lost to follow-up or at the time of death. The cohorts were categorized into low (<= 30%), intermediate (31-69%), and high (>= 70%) RM compliance groups. Statistical analyses were conducted accordingly.Results: Among 853 patients, median RM compliance was 55%. Age inversely affected compliance (p < .001), and high compliance was associated with guideline-directed medical therapy (GDMT) usage and implantable cardioverter defibrillator (ICD)/cardiac resynchronization defibrillator (CRTD) devices. The low-compliance group had a higher mortality rate and fewer regular clinic visits (p < .001) than high-compliance group. Socioeconomic factors did not significantly impact compliance, while Asians showed higher compliance compared with Whites (OR 3.67; 95% CI 1.08-12.43; p = .04). Technical issues were the main reason for non-compliance.Conclusion: We observed suboptimal compliance to RM, which occurred most frequently in older patients. Clinic visit compliance, optimal medical therapy, and lower mortality were associated with higher compliance, whereas insufficient understanding of RM usage was the chief barrier to compliance.Keywords
All Related Versions
This publication has 33 references indexed in Scilit:
- Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trial - testing execution of the recommendationsEuropean Heart Journal, 2014
- Compliance with Remote Monitoring of ICDS/CRTDS in a Real‐World PopulationPacing and Clinical Electrophysiology, 2014
- Use of Remote Monitoring of Newly Implanted Cardioverter-DefibrillatorsCirculation, 2013
- A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trialEuropean Heart Journal, 2012
- A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial)European Heart Journal, 2011
- The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) TrialJACC, 2011
- Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-UpCirculation, 2010
- Sex and Racial Differences in the Use of Implantable Cardioverter-Defibrillators Among Patients Hospitalized With Heart FailureJAMA, 2007
- Racial Disparity in the Utilization of Implantable-Cardioverter Defibrillators Among Patients With Prior Myocardial Infarction and an Ejection Fraction of ≤35%The American Journal of Cardiology, 2007
- Variation in cardiac procedure use and racial disparity among Veterans Affairs HospitalsAmerican Heart Journal, 2007